Table of Contents
ISRN Oncology
Volume 2012, Article ID 721612, 15 pages
http://dx.doi.org/10.5402/2012/721612
Research Article

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma

1Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Science, Lavrentiev Avenue 8, Novosibirsk 630090, Russia
2Novosibirsk State Medical University, Krasnyi Prospect 52, Novosibirsk 630091, Russia

Received 21 September 2012; Accepted 15 October 2012

Academic Editors: Y. Akiyama and D. Canuti

Copyright © 2012 Alexandra V. Sen'kova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Sanderson, R. A. Brain, D. J. Johnson, C. J. Wilson, and K. R. Solomon, “Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones,” Toxicology, vol. 203, no. 1–3, pp. 27–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Wollmer and A. Neubauer, “Side effects of tumor pharmacotherapy. What internists should know,” Internist, vol. 52, no. 12, pp. 1429–1445, 2011. View at Google Scholar
  3. D. S. Marques, J. Z. Sandrini, R. T. Boyle, L. F. Marins, and G. S. Trindade, “Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines,” Leukemia Research, vol. 34, no. 6, pp. 757–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Tsiftsoglou, I. S. Pappas, and I. S. Vizirianakis, “Mechanisms involved in the induced differentiation of leukemia cells,” Pharmacology and Therapeutics, vol. 100, no. 3, pp. 257–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Shtil, “Emergence of multidrug resistance in leukemia cells during chemotherapy: mechanisms and prevention,” Journal of Hematotherapy and Stem Cell Research, vol. 11, no. 2, pp. 231–241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Stavrovskaya, “Cellular mechanisms of multidrug resistance of tumor cells,” Biochemistry, vol. 65, no. 1, pp. 95–106, 2000. View at Google Scholar · View at Scopus
  7. A. A. Stavrovskaya and T. P. Stromskaya, “Transport proteins of the ABC family and multidrug resistance of tumor cells,” Biochemistry, vol. 73, no. 5, pp. 592–604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. T. Maung, F. R. MacLean, M. M. Reid et al., “The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia,” British Journal of Haematology, vol. 88, no. 1, pp. 105–109, 1994. View at Google Scholar · View at Scopus
  9. M. Filipits, “Mechanisms of cancer: multidrug resistance,” Drug Discovery Today, vol. 1, no. 2, pp. 229–234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. S. Chauhan, B. Bhushan, L. C. Singh et al., “Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy,” Experimental and Molecular Pathology, vol. 92, no. 1, pp. 44–49, 2011. View at Google Scholar
  11. P. D. King and M. C. Perry, “Hepatotoxicity of chemotherapy,” Oncologist, vol. 6, no. 2, pp. 162–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters, “Mechanisms of hepatotoxicity,” Toxicological Sciences, vol. 65, no. 2, pp. 166–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Mironova, O. Shklyaeva, E. Andreeva et al., “Animal model of drug-resistant tumor progression,” Annals of the New York Academy of Sciences, vol. 91, pp. 490–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Chattopadhyay, R. Kher, and M. Godbole, “Inexpensive SDS/phenol method for RNA extraction from tissues.,” BioTechniques, vol. 15, no. 1, pp. 24–26, 1993. View at Google Scholar · View at Scopus
  15. O. A. Patutina, N. L. Mironova, N. A. Popova et al., “The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy,” BMC Cancer, vol. 10, p. 204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. I. V. Viktorov and S. S. Proshin, “Use of isopropyl alcohol in histological assays: dehydration of tissue, enbessing into paraffin, and processing of paraffin sections,” Bulletin of Experimental Biology and Medicine, vol. 136, no. 1, pp. 105–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Buesa and M. V. Peshkov, “Histology without xylene,” Annals of Diagnostic Pathology, vol. 13, no. 4, pp. 246–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. R. Weibel, Stereological Methods. Practical Methods for Biological Morphometry, Academic Press, London, UK, 1979.
  19. G. G. Avtandilov, Medical Morphometry, Medicine, Moscow, Russia, 1990.
  20. L. D. True, “Morphometric applications in anatomic pathology,” Human Pathology, vol. 27, no. 5, pp. 450–467, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Pascahle, M. C. Miller, C. Chiu et al., “Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent,” Fluids and Barriers of the CNS, vol. 8, p. 21, 2011. View at Google Scholar
  22. K. Hoffmann and W. Löscher, “Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR-rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats,” Epilepsia, vol. 48, no. 4, pp. 631–645, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Shi, D. Lu, Y. Shu, W. Shi, S. Lu, and K. Wang, “Expression of multidrug resistance-related proteins p-glycoproteinglutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma,” Cancer Investigation, vol. 26, no. 4, pp. 344–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Petterino, E. Rossetti, D. Bertoncello et al., “Immunohistochemical detection of P-glycoprotein (Clone C494) in canine mammary gland tumours,” Journal of Veterinary Medicine A, vol. 53, no. 4, pp. 174–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. I. O. L. Ng, C. L. Liu, S. T. Fan, and M. Ng, “Expression of P-glycoprotein in hepatocellular carcinoma: a determinant of chemotherapy response,” American Journal of Clinical Pathology, vol. 113, no. 3, pp. 355–363, 2000. View at Google Scholar · View at Scopus
  26. A. N. Zenkov, N. V. Scvortsova, E. L. Chernolovskaya, T. I. Pospelova, and V. V. Vlassov, “Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement,” Nucleosides, Nucleotides and Nucleic Acids, vol. 23, no. 6-7, pp. 843–847, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Kasimir-Bauer, D. Beelen, M. Flasshove, R. Noppeney, S. Seeber, and M. E. Scheulen, “Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia,” Experimental Hematology, vol. 30, no. 11, pp. 1302–1308, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Gibalová, M. Sereš, A. Rusnák et al., “P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation,” Toxicol in Vitro, vol. 26, no. 3, pp. 435–444, 2012. View at Google Scholar
  29. T. R. Stouch and O. Gudmundsson, “Progress in understanding the structure-activity relationships of P-glycoprotein,” Advanced Drug Delivery Reviews, vol. 54, no. 3, pp. 315–328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kourti, N. Vavatsi, N. Gombakis et al., “Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia,” International Journal of Hematology, vol. 86, no. 2, pp. 166–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Komdeur, B. E. C. Plaat, W. T. A. Van Der Graaf et al., “Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade,” European Journal of Cancer, vol. 39, no. 7, pp. 909–916, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Oue, A. Yoneda, S. Uehara, H. Yamanaka, and M. Fukuzawa, “Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies,” Journal of Pediatric Surgery, vol. 44, no. 2, pp. 377–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Mahmood, M. J. Daood, C. Hart, T. W. R. Hansen, and J. F. Watchko, “Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney,” Journal of Investigative Medicine, vol. 49, no. 3, pp. 250–257, 2001. View at Google Scholar · View at Scopus
  34. R. Ludwig, A. Weirich, U. Abel, W. Hofmann, N. Graf, and M. F. Tournade, “Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH,” Medical and Pediatric Oncology, vol. 33, no. 5, pp. 462–469, 1999. View at Google Scholar
  35. J. Floyd, I. Mirza, B. Sachs, and M. C. Perry, “Hepatotoxicity of chemotherapy,” Seminars in Oncology, vol. 33, no. 1, pp. 50–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Gonzalez-Angulo, F. Morales-Vasquez, and G. N. Hortobagyi, “Overview of resistance to systemic therapy in patients with breast cancer,” Advances in Experimental Medicine and Biology, vol. 608, pp. 1–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Hartmann, H. Kim, and M. Piquette-Miller, “Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice,” International Immunopharmacology, vol. 1, no. 2, pp. 189–199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Staibano, R. Franco, F. Tranfa et al., “Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior,” Anticancer Research, vol. 24, no. 1, pp. 249–257, 2004. View at Google Scholar · View at Scopus
  39. N. M. Tretiak, M. I. Anoshina, and V. M. Mnishenko, “Endogenous intoxication, immunological reactivity and erythrocyte membrane permeability in patients with chronic myelogenous leukemia,” Likars"ka sprava, no. 5-6, pp. 64–67, 2001. View at Google Scholar · View at Scopus
  40. N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama, “Impact of drug transporter studies on drug discovery and development,” Pharmacological Reviews, vol. 55, no. 3, pp. 425–461, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. J. Endres, P. Hsiao, F. S. Chung, and J. D. Unadkat, “The role of transporters in drug interactions,” European Journal of Pharmaceutical Sciences, vol. 27, no. 5, pp. 501–517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Tygstrup, K. Bangert, P. Ott, and H. C. Bisgaard, “Messenger RNA profiles in liver injury and stress: a comparison of lethal and nonlethal rat models,” Biochemical and Biophysical Research Communications, vol. 290, no. 1, pp. 518–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Staud, M. Ceckova, S. Micuda, and P. Pavek, “Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.,” Methods in Molecular Biology, vol. 596, pp. 199–222, 2010. View at Google Scholar · View at Scopus
  44. B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi, “Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system,” Physiological Reviews, vol. 86, no. 4, pp. 1179–1236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. D. L. Gustafson and M. E. Long, “Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens,” Chemico-Biological Interactions, vol. 138, no. 1, pp. 43–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. M. O. Islam, M. Hara, and J. Miyake, “Induction of P-glycoprotein, glutathione-S-transferase and cytochrome P450 in rat liver by atrazine,” Environmental Toxicology and Pharmacology, vol. 12, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Hartmann, V. Vassileva, and M. Piquette-Miller, “Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice,” Drug Metabolism and Disposition, vol. 33, no. 6, pp. 820–828, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Kageyama, K. Fukushima, T. Togawa et al., “Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers,” Biological and Pharmaceutical Bulletin, vol. 29, no. 4, pp. 779–784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. L. M. Aleksunes, G. L. Scheffer, A. B. Jakowski, I. M. Pruimboom-Brees, and J. E. Manautou, “Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury,” Toxicological Sciences, vol. 89, no. 2, pp. 370–379, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. S. N. Barnes, L. M. Aleksunes, L. Augustine et al., “Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases,” Drug Metabolism and Disposition, vol. 35, no. 10, pp. 1963–1969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Fromm, “P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs,” International Journal of Clinical Pharmacology and Therapeutics, vol. 38, no. 2, pp. 69–74, 2000. View at Google Scholar · View at Scopus